CLOV vs NEO · rev $1.37B vs $924.0M cap
Clover Health Investments Corp (CLOV) versus NeoGenomics Inc (NEO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
NeoGenomics Inc (NEO) is a diagnostics & research company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
NEO does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. NEO currently screens at market cap $924.0M.
Not investment advice. Open the CLOV and NEO stock pages for the full models.
Not investment advice.